285 related articles for article (PubMed ID: 31550641)
21. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
Golub V; Reddy DS
Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
[TBL] [Abstract][Full Text] [Related]
22. Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?
Uliel-Sibony S; Hausman-Kedem M; Fattal-Valevski A; Kramer U
Brain Dev; 2021 Jan; 43(1):89-96. PubMed ID: 32713661
[TBL] [Abstract][Full Text] [Related]
23. Second-line cannabis therapy in patients with epilepsy.
Braun E; Gualano FM; Siddarth P; Segal E
Clin Neurol Neurosurg; 2023 Apr; 227():107638. PubMed ID: 36870086
[TBL] [Abstract][Full Text] [Related]
24. Cannabis-based products for pediatric epilepsy: A systematic review.
Elliott J; DeJean D; Clifford T; Coyle D; Potter BK; Skidmore B; Alexander C; Repetski AE; Shukla V; McCoy B; Wells GA
Epilepsia; 2019 Jan; 60(1):6-19. PubMed ID: 30515765
[TBL] [Abstract][Full Text] [Related]
25. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy.
Wheless JW; Dlugos D; Miller I; Oh DA; Parikh N; Phillips S; Renfroe JB; Roberts CM; Saeed I; Sparagana SP; Yu J; Cilio MR;
CNS Drugs; 2019 Jun; 33(6):593-604. PubMed ID: 31049885
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
[TBL] [Abstract][Full Text] [Related]
28. Cannabis-based magistral formulation is highly effective as an adjuvant treatment in drug-resistant focal epilepsy in adult patients: an open-label prospective cohort study.
Navarro CE
Neurol Sci; 2023 Jan; 44(1):297-304. PubMed ID: 36129615
[TBL] [Abstract][Full Text] [Related]
29. Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol.
Szaflarski JP; Hernando K; Bebin EM; Gaston TE; Grayson LE; Ampah SB; Moreadith R
Epilepsy Behav; 2019 Jun; 95():131-136. PubMed ID: 31048098
[TBL] [Abstract][Full Text] [Related]
30. Practical considerations in medical cannabis administration and dosing.
MacCallum CA; Russo EB
Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
[TBL] [Abstract][Full Text] [Related]
31. Cannabis and cannabinoids.
Med Lett Drugs Ther; 2016 Aug; 58(1500):97-8. PubMed ID: 27466748
[No Abstract] [Full Text] [Related]
32. Cannabis for Pediatric Epilepsy.
Huntsman RJ; Tang-Wai R; Shackelford AE
J Clin Neurophysiol; 2020 Jan; 37(1):2-8. PubMed ID: 31895184
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy and safety of cannabidiol (CBD) in children with treatment-resistant epilepsy: Results from a state-based expanded access program.
Park YD; Linder DF; Pope J; Flamini JR; Moretz K; Diamond MP; Long SA
Epilepsy Behav; 2020 Nov; 112():107474. PubMed ID: 33181893
[TBL] [Abstract][Full Text] [Related]
34. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA
Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682
[TBL] [Abstract][Full Text] [Related]
35. Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy-Analysis from the UK Medical Cannabis Registry.
Erridge S; Holvey C; Coomber R; Hoare J; Khan S; Platt MW; Rucker JJ; Weatherall MW; Beri S; Sodergren MH
Neuropediatrics; 2023 Jun; 54(3):174-181. PubMed ID: 36539215
[TBL] [Abstract][Full Text] [Related]
36. Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results.
Szaflarski JP; Bebin EM; Comi AM; Patel AD; Joshi C; Checketts D; Beal JC; Laux LC; De Boer LM; Wong MH; Lopez M; Devinsky O; Lyons PD; Zentil PP; Wechsler R;
Epilepsia; 2018 Aug; 59(8):1540-1548. PubMed ID: 29998598
[TBL] [Abstract][Full Text] [Related]
37. Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: A study of eight patients.
Caraballo R; Valenzuela GR
Seizure; 2021 Nov; 92():238-243. PubMed ID: 34624613
[TBL] [Abstract][Full Text] [Related]
38. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP; Bebin EM
Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
[TBL] [Abstract][Full Text] [Related]
39. Observational study of medical marijuana as a treatment for treatment-resistant epilepsies.
Devinsky O; Marmanillo A; Hamlin T; Wilken P; Ryan D; Anderson C; Friedman D; Todd G
Ann Clin Transl Neurol; 2022 Apr; 9(4):497-505. PubMed ID: 35267245
[TBL] [Abstract][Full Text] [Related]
40. The Long-Term Effectiveness and Safety of Cannabidiol-Enriched Oil in Children With Drug-Resistant Epilepsy.
Tzadok M; Hamed N; Heimer G; Zohar-Dayan E; Rabinowicz S; Ben Zeev B
Pediatr Neurol; 2022 Nov; 136():15-19. PubMed ID: 36049378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
